CN104931620B - The separation of Gynura procumbens (Lour.) Merr. Content of Chlorogenic Acid constituents and content assaying method - Google Patents
The separation of Gynura procumbens (Lour.) Merr. Content of Chlorogenic Acid constituents and content assaying method Download PDFInfo
- Publication number
- CN104931620B CN104931620B CN201510388257.3A CN201510388257A CN104931620B CN 104931620 B CN104931620 B CN 104931620B CN 201510388257 A CN201510388257 A CN 201510388257A CN 104931620 B CN104931620 B CN 104931620B
- Authority
- CN
- China
- Prior art keywords
- acid
- dicaffeoylquinic
- chlorogenic
- dicaffeoylquinic acid
- lour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 title claims abstract description 86
- 235000001368 chlorogenic acid Nutrition 0.000 title claims abstract description 53
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 title claims abstract description 51
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 title claims abstract description 51
- 229940074393 chlorogenic acid Drugs 0.000 title claims abstract description 51
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 title claims abstract description 51
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 title claims abstract description 51
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 37
- 240000008672 Gynura procumbens Species 0.000 title claims abstract description 32
- 235000018457 Gynura procumbens Nutrition 0.000 title claims abstract description 32
- 238000000926 separation method Methods 0.000 title description 6
- 239000000470 constituent Substances 0.000 title description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 54
- UFCLZKMFXSILNL-PSEXTPKNSA-N Isochlorogenic acid b Chemical compound O([C@@H]1C[C@@](O)(C[C@H]([C@H]1OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)O)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 UFCLZKMFXSILNL-PSEXTPKNSA-N 0.000 claims abstract description 47
- UFCLZKMFXSILNL-BKUKFAEQSA-N 3,4-di-O-caffeoylquinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O UFCLZKMFXSILNL-BKUKFAEQSA-N 0.000 claims abstract description 46
- 239000013558 reference substance Substances 0.000 claims abstract description 31
- GWTUHAXUUFROTF-UHFFFAOYSA-N pseudochlorogenic acid Natural products C1C(O)C(O)C(O)CC1(C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 GWTUHAXUUFROTF-UHFFFAOYSA-N 0.000 claims abstract description 28
- CWVRJTMFETXNAD-NXLLHMKUSA-N trans-5-O-caffeoyl-D-quinic acid Chemical compound O[C@H]1[C@H](O)C[C@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-NXLLHMKUSA-N 0.000 claims abstract description 28
- UFCLZKMFXSILNL-BBLPPJRLSA-N (-) 4,5-dicaffeoylquinic acid Natural products OC=1C=C(C=CC=1O)C=CC(=O)O[C@@H]1C[C@@](C[C@H]([C@H]1OC(C=CC1=CC(=C(C=C1)O)O)=O)O)(C(=O)O)O UFCLZKMFXSILNL-BBLPPJRLSA-N 0.000 claims abstract description 25
- UFCLZKMFXSILNL-UHFFFAOYSA-N NSC 649410 Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC1C(O)CC(O)(C(O)=O)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 UFCLZKMFXSILNL-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000523 sample Substances 0.000 claims abstract description 25
- KRZBCHWVBQOTNZ-PSEXTPKNSA-N 3,5-di-O-caffeoyl quinic acid Chemical compound O([C@@H]1C[C@](O)(C[C@H]([C@@H]1O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 KRZBCHWVBQOTNZ-PSEXTPKNSA-N 0.000 claims abstract description 24
- MVCIFQBXXSMTQD-UHFFFAOYSA-N 3,5-dicaffeoylquinic acid Natural products Cc1ccc(C=CC(=O)OC2CC(O)(CC(OC(=O)C=Cc3ccc(O)c(O)c3)C2O)C(=O)O)cc1C MVCIFQBXXSMTQD-UHFFFAOYSA-N 0.000 claims abstract description 23
- UFCLZKMFXSILNL-AALYGJCLSA-N 3,4-Dicaffeoylquinic acid Natural products O=C(O[C@@H]1[C@H](OC(=O)/C=C/c2cc(O)c(O)cc2)C[C@](O)(C(=O)O)C[C@@H]1O)/C=C/c1cc(O)c(O)cc1 UFCLZKMFXSILNL-AALYGJCLSA-N 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 239000012488 sample solution Substances 0.000 claims abstract description 15
- 238000012937 correction Methods 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 14
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 238000010812 external standard method Methods 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 235000014666 liquid concentrate Nutrition 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims 2
- 238000007796 conventional method Methods 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 230000003595 spectral effect Effects 0.000 claims 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 abstract description 7
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 230000014759 maintenance of location Effects 0.000 description 6
- -1 terpene Alkene Chemical class 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KRZBCHWVBQOTNZ-UHFFFAOYSA-N (-) 3,5-dicaffeoyl-muco-quinic acid Natural products OC1C(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC(O)(C(O)=O)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 KRZBCHWVBQOTNZ-UHFFFAOYSA-N 0.000 description 1
- KRZBCHWVBQOTNZ-RDJMKVHDSA-M (-)-3,5-Dicaffeoyl quinic acid Natural products O([C@@H]1CC(O)(C[C@H](C1O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C([O-])=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 KRZBCHWVBQOTNZ-RDJMKVHDSA-M 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- NVJZCEJMTWDVFK-OTHZMAGNSA-N C(\C=C\C1=CC(O)=C(O)C=C1)(=O)[C@]1(CC(C[C@](C1O)(O)C(\C=C\C1=CC(O)=C(O)C=C1)=O)(C(=O)O)O)O.C(\C=C\C1=CC(O)=C(O)C=C1)(=O)[C@]1(CC(C[C@](C1O)(O)C(\C=C\C1=CC(O)=C(O)C=C1)=O)(C(=O)O)O)O Chemical compound C(\C=C\C1=CC(O)=C(O)C=C1)(=O)[C@]1(CC(C[C@](C1O)(O)C(\C=C\C1=CC(O)=C(O)C=C1)=O)(C(=O)O)O)O.C(\C=C\C1=CC(O)=C(O)C=C1)(=O)[C@]1(CC(C[C@](C1O)(O)C(\C=C\C1=CC(O)=C(O)C=C1)=O)(C(=O)O)O)O NVJZCEJMTWDVFK-OTHZMAGNSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000157855 Cinchona Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241001558017 Gynura Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical class C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000001646 magnetic resonance method Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 125000003410 quininyl group Chemical group 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510388257.3A CN104931620B (en) | 2015-07-03 | 2015-07-03 | The separation of Gynura procumbens (Lour.) Merr. Content of Chlorogenic Acid constituents and content assaying method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510388257.3A CN104931620B (en) | 2015-07-03 | 2015-07-03 | The separation of Gynura procumbens (Lour.) Merr. Content of Chlorogenic Acid constituents and content assaying method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104931620A CN104931620A (en) | 2015-09-23 |
CN104931620B true CN104931620B (en) | 2017-03-08 |
Family
ID=54118888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510388257.3A Active CN104931620B (en) | 2015-07-03 | 2015-07-03 | The separation of Gynura procumbens (Lour.) Merr. Content of Chlorogenic Acid constituents and content assaying method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104931620B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107721857B (en) * | 2017-10-25 | 2020-10-09 | 江西省科学院应用化学研究所 | Method for preparing high-purity chlorogenic acid from gynura procumbens |
CN107951915A (en) * | 2017-12-12 | 2018-04-24 | 江西天元药业有限公司 | For improving cardiovascular raising immunity and antitumor Gynura procumbens (Lour.) Merr extract |
CN108619203B (en) * | 2018-06-22 | 2021-07-13 | 深圳市本源生物科技有限公司 | Application of gynura procumbens in preparation of medicine for treating ulcerative colitis |
CN108689852B (en) * | 2018-06-26 | 2021-01-26 | 江西省科学院应用化学研究所 | Method for extracting chlorogenic acid and isochlorogenic acid from gynura procumbens |
CN111892503B (en) * | 2020-08-11 | 2023-01-24 | 江西省科学院应用化学研究所 | Method for rapidly preparing high-purity chlorogenic acid from gynura procumbens |
CN112903841A (en) * | 2021-01-18 | 2021-06-04 | 中国检验检疫科学研究院 | Method for detecting isomers of chlorogenic acids |
-
2015
- 2015-07-03 CN CN201510388257.3A patent/CN104931620B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104931620A (en) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104931620B (en) | The separation of Gynura procumbens (Lour.) Merr. Content of Chlorogenic Acid constituents and content assaying method | |
CN102749348B (en) | Method for identifying active components in medicinal plant | |
CN105606734B (en) | A kind of quick high separation liquid chromatographic detection honeysuckle and the method for Honeysuckle flower medicinal material | |
CN105241980B (en) | Rapid separation liquid chromatography detection method for naoxintong capsules | |
Müller et al. | Analysis of phenolic glycosides and saponins in Primula elatior and Primula veris (primula root) by liquid chromatography, evaporative light scattering detection and mass spectrometry | |
CN110554108B (en) | Quality detection method for lindley eupatorium herb | |
Yang et al. | Quantitative analysis of four major diterpenoids in Andrographis paniculata by 1H NMR and its application for quality control of commercial preparations | |
CN106525997A (en) | Method for determination of organic acids and flavone components in polygonum viviparum | |
Lee et al. | Quantification of isoflavonoids and triterpene saponins in Astragali Radix, the root of Astragalus membranaceus, via reverse-phase high-performance liquid chromatography coupled with integrated pulsed amperometric detection | |
CN106526033A (en) | Method for simultaneously testing 11 macamides content of maca | |
CN110346462A (en) | Leaf of Moringa UPLC fingerprint and its UPLC finger-print | |
He et al. | Differentiation of Cuscuta chinensis and Cuscuta australis by HPLC-DAD-MS analysis and HPLC-UV quantitation | |
CN102749399B (en) | Method for detecting caffeic acid content in tobacco | |
CN103575830B (en) | The analysis method of 4 kinds of anthraquinones and its application in pharmacokinetics in blood plasma | |
Chu et al. | Transformation of astragalosides from Radix Astragali under acidic, neutral, and alkaline extraction conditions monitored by LC-ESI-TOF/MS | |
CN104374854B (en) | A kind of method of multiple phenolic content in HPLC wavelength handoff technique Simultaneously test Noni juice | |
AU2020100932A4 (en) | Method for Determining Content of Kaempferol-3-O-rutinoside in Herba Et Radix Tetrastigmae Hemsleyana | |
CN103808751B (en) | A kind of method differentiating traditional Chinese medicine honeysuckle or spin-off | |
CN102552476B (en) | Quality control method for Rosa laevigata root | |
Han et al. | Isolation and purification of Pseudostellarin B (cyclic peptide) from Pseudostellaria heterophylla (Miq.) Pax by high-speed counter-current chromatography | |
Qin et al. | Ultrasonic-assisted liquid–liquid extraction and HILIC–ELSD analysis of ginsenoside Rb1, astragaloside IV and dulcitol in sugar-free “Fufangfufangteng Heji” | |
CN103940942B (en) | A kind of detection method of CHANGYANNING preparation | |
CN103175910A (en) | Method for controlling quality of liquorice and liquorice preparation | |
CN108414666A (en) | The assay method of gingerol content in a kind of ginger medicinal material extractive of volatile oil | |
CN107748211A (en) | A kind of method using 5 kinds of macamides in deep co-melting solvent extraction measure maca |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170324 Address after: 518000 Guangdong city of Shenzhen province Futian District Shatou street Che Kung Temple Tairan six road cedar building B, 9A Patentee after: SHENZHEN BENYUAN BIOTECHNOLOGY CO.,LTD. Address before: Room 13, building 182, national Avenue, Hongshan District, Hubei, Wuhan, 430074, China Patentee before: Tang Hebin |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180102 Address after: Room 13, building 182, national Avenue, Hongshan District, Hubei, Wuhan, 430074, China Patentee after: Tang Hebin Address before: 518000 Guangdong city of Shenzhen province Futian District Shatou street Che Kung Temple Tairan six road cedar building B, 9A Patentee before: SHENZHEN BENYUAN BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210330 Address after: 430074 No. 182, National Road, Hongshan District, Wuhan, Hubei Patentee after: SOUTH CENTRAL University FOR NATIONALITIES Address before: 430074 room 222, building 13, 182 Minzu Avenue, Hongshan District, Wuhan City, Hubei Province Patentee before: Tang Hebin |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210518 Address after: 518131 1002c, block B, Nanxian Commercial Plaza, Nanyuan new village, North Station community, Minzhi street, Longhua District, Shenzhen City, Guangdong Province Patentee after: SHENZHEN BENYUAN BIOTECHNOLOGY Co.,Ltd. Address before: 430074 No. 182, National Road, Hongshan District, Wuhan, Hubei Patentee before: SOUTH CENTRAL University FOR NATIONALITIES |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230703 Address after: 410011 502, Building F1, Lemon Lidu, Xinyao Road Crossing, Tianxin District, Changsha, Hunan Province Patentee after: Tan Yulian Address before: 518131 1002c, block B, Nanxian Commercial Plaza, Nanyuan new village, North Station community, Minzhi street, Longhua District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN BENYUAN BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230905 Address after: Room 1303, Building 5, Xijia District, No. 182 Minzu Avenue, Hongshan District, Wuhan City, Hubei Province, 430074 Patentee after: Tang Hebin Address before: 410011 502, Building F1, Lemon Lidu, Xinyao Road Crossing, Tianxin District, Changsha, Hunan Province Patentee before: Tan Yulian |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240328 Address after: Room 1501, Block B, Nanxian Commercial Plaza, Nanyuan New Village, North Station Community, Minzhi Street, Longhua District, Shenzhen, Guangdong 518000 Patentee after: Shenzhen Renfu Biotechnology Co.,Ltd. Country or region after: China Address before: Room 1303, Building 5, Xijia District, No. 182 Minzu Avenue, Hongshan District, Wuhan City, Hubei Province, 430074 Patentee before: Tang Hebin Country or region before: China |